Immune cells have a backup mechanism.
In: Medical Letter on the CDC & FDA, 2023-04-02, S. 826
serialPeriodical
Zugriff:
Keywords: Clinical Chemistry; Coronavirus; Drugs and Therapies; Enzymes and Coenzymes; Genetics; Hospitals; Immunology; Kinase; RNA Viruses; Risk and Prevention; University of Bonn; Viral; Virology; Virus EN Clinical Chemistry Coronavirus Drugs and Therapies Enzymes and Coenzymes Genetics Hospitals Immunology Kinase RNA Viruses Risk and Prevention University of Bonn Viral Virology Virus 826 826 1 03/27/23 20230402 NES 230402 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- The enzyme TBK1 is an important component of the innate immune system that plays a critical role in the defense against viruses. "A second enzyme that is very similar to TBK1 plays an important role in this: the IkB kinase epsilon, or IKKepsilon for short", explains Dr. Julia Wegner, first author of the study. Until now, it was unclear why a complete loss of TBK1 expression is better tolerated in terms of immunocompetence than a mutation of TBK1 affecting the kinase function. [Extracted from the article]
Copyright of Medical Letter on the CDC & FDA is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Immune cells have a backup mechanism.
|
---|---|
Zeitschrift: | Medical Letter on the CDC & FDA, 2023-04-02, S. 826 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1532-4648 (print) |
Sonstiges: |
|